| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Afisi S Ismaila | Q88722206 |
| Shiyuan Zhang | Q90247169 | ||
| Denise King | Q90247174 | ||
| P2093 | author name string | Virginia M Rosen | |
| P2860 | cites work | Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma | Q83193567 |
| Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial | Q86029023 | ||
| Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial | Q46281641 | ||
| A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma | Q46413967 | ||
| Adherence to asthma controller medication regimens | Q46685058 | ||
| Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics | Q46977563 | ||
| The Economic Burden of Asthma in the United States, 2008 - 2013. | Q50090339 | ||
| Bronchodilation of formoterol administered with budesonide: device and formulation effects. | Q50957169 | ||
| Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. | Q51099252 | ||
| Fixed-Dose Combination Inhalers. | Q51122644 | ||
| A novel allergen Tab y 1 with inhibitory activity of platelet aggregation from salivary glands of horseflies. | Q52726105 | ||
| Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. | Q53242470 | ||
| Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement | Q56880247 | ||
| Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma | Q73398082 | ||
| Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma | Q74098152 | ||
| Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers | Q77321212 | ||
| Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma | Q80207118 | ||
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients | Q22305515 | ||
| Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States | Q26858945 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
| The impact of combined inhaled bronchodilator therapy in the treatment of COPD. | Q31828672 | ||
| Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups | Q33844382 | ||
| Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children | Q34325876 | ||
| Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. | Q34579583 | ||
| Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. | Q35007081 | ||
| COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study | Q36714414 | ||
| Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children | Q36729964 | ||
| Exploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol). | Q36953965 | ||
| Adherence to anti-inflammatory treatment for asthma in clinical practice in France | Q37221718 | ||
| Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study | Q37247499 | ||
| A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD. | Q38387276 | ||
| Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD. | Q38457335 | ||
| Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler | Q38496241 | ||
| Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma | Q38707759 | ||
| Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. | Q39387714 | ||
| The clinical and economic burden of chronic obstructive pulmonary disease in the USA. | Q41548699 | ||
| Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma. | Q42917950 | ||
| Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment | Q43178450 | ||
| Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone | Q43723874 | ||
| Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma. | Q44093058 | ||
| Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers | Q44191066 | ||
| Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD. | Q44458630 | ||
| One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma | Q44482599 | ||
| Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies | Q44758825 | ||
| A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids. | Q45202960 | ||
| Inhaler mishandling remains common in real life and is associated with reduced disease control | Q45494707 | ||
| Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler | Q45853610 | ||
| Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens. | Q45959057 | ||
| Lung function and asthma control with beclomethasone and formoterol in a single inhaler | Q46269422 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | systematic review | Q1504425 |
| asthma | Q35869 | ||
| P304 | page(s) | 417-438 | |
| P577 | publication date | 2020-02-26 | |
| P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
| P1476 | title | Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review | |
| P478 | volume | 15 |
Search more.